Gallo hired to lead strategic Systems Pharmacology Initiative

“We are very pleased to bring Dr. Gallo on board,” says James M. O’Donnell, dean. “His expertise in quantitative systems pharmacology will help position the school to lead contemporary approaches in science and practice within this important emerging field.”

Gallo was previously the chair of pharmaceutical sciences at the Albany College of Pharmacy and Health Sciences. His research has focused on experimental therapeutics of anticancer drugs using quantitative systems pharmacology and pharmacokinetic and pharmacodynamics modeling approaches to advance drug development and improve drug therapy of brain tumors.

He is the author of over 140 publications and has been the principal investigator on numerous NIH RO1 grants. He is a member of editorial advisory boards for the Journal of Pharmacokinetics and Pharmacodynamics, Clinical Pharmacology and Therapeutics: Pharmacometrics and Systems Pharmacology, and PLOS – Computational Biology.

In July 2017, the School of Pharmacy and Pharmaceutical Sciences was awarded $1 million from the State University of New York (SUNY) Empire Innovation Program, an initiative dedicated to recruiting and retaining world-class faculty. Gallo’s hire is a strategic component of this program.

“The Department of Pharmaceutical Sciences welcomes Dr. Gallo to lead our systems pharmacology initiative,” says Marilyn Morris, SUNY Distinguished Professor and Chair, Department of Pharmaceutical Sciences. ”His appointment will enable us to develop a next-generation platform for translational medicine, by predicting drug action at the individual level based on patient characteristics, and will enhance UB’s current research strength and training programs in pharmacokinetics/pharmacodynamics and systems pharmacology.”   

Gallo’s start date is July 2.